Human Umbilical Cord-Derived Mesenchymal Stem Cell Production In Corning® HYPERStack® 36-Layer Cell Culture Vessels

By Hilary Sherman and John Shyu, Corning Life Sciences

Explore a robust method for significantly scaling up human umbilical cord-derived mesenchymal stem cell production. This application note details a process that consistently yields over a billion cells per vessel, while ensuring exceptional viability, with an average of over 85%. Furthermore, the harvested cells maintain critical identity markers, expressing greater than 99% of CD90, CD105, and CD73. This approach addresses the increasing demand for high-quality, large-quantity mesenchymal stem cells in therapeutic applications.

Learn more about these promising results and the methodology behind them. Read the full application note to optimize your cell culture processes.